Analytical Data
-
Gene name
Versican Isoform V0
- Application
-
Alternative Names
CSPG2; VS; ERVR; PG-M; WGN1; Chondroitin Sulfate Proteoglycan 2; Chondroitin sulfate proteoglycan core protein 2; Glial hyaluronate-binding; Large fibroblast proteoglycan
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P13611
-
Expression Region
Thr2958~Ser3209
-
Molecular Weight
38kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Versican is a large extracellular matrix proteoglycan that plays a crucial role in various biological processes, including cell adhesion, proliferation, and migration. It exists in multiple isoforms, with isoform V0 being one of the most studied due to its significant involvement in tissue remodeling and repair, particularly in the cardiovascular system. Research on Versican isoform V0 has highlighted its importance in diseases such as atherosclerosis, cancer, and osteoarthritis, where its expression levels can be markedly altered. The recombinant protein of Versican isoform V0 has emerged as a valuable tool for studying its functional properties and interactions with other extracellular matrix components. Investigating this isoform's structural characteristics and biological functions helps to elucidate its role in health and disease. Furthermore, recombinant Versican V0 offers potential therapeutic applications, such as developing biomaterials for tissue engineering and regenerative medicine. Overall, the study of Versican isoform V0 recombinant protein is essential for understanding its impact on various physiological and pathological processes, paving the way for novel diagnostic and therapeutic strategies.
